Post-COVID-19 Patients Suffer from Chemosensory, Trigeminal, and Salivary Dysfunctions

Overview

Journal Sci Rep

Specialty Science

Date 2024 Feb 11

PMID 38342941

Authors

Asmund Rogn

Janicke Liaaen Jensen

Per Ole Iversen

Preet Bano Singh

Affiliations

Soon will be listed here.

Abstract

Recent literature indicates that post-COVID-19 patients suffer from a plethora of complications, including chemosensory dysfunction. However, little attention has been given to understand the interactions between chemosensory, trigeminal, and salivary dysfunctions in these patients. The aims of this study were (1) to investigate the prevalence and combinations of chemosensory, trigeminal, and salivary dysfunctions, (2) to identify the odorants/tastants that are compromised, and (3) to explore possible associations between the four dysfunctions in post-COVID-19 patients. One hundred post-COVID-19 patients and 76 healthy controls (pre-COVID-19) were included in this cross-sectional, case-controlled study. Participants' smell, taste, trigeminal, and salivary functions were assessed. The patients had a significantly higher prevalence of parosmia (80.0%), hyposmia (42.0%), anosmia (53.0%), dysgeusia (34.0%), complete ageusia (3.0%), specific ageusia (27.0%), dysesthesia (11.0%) and dry mouth (18.0%) compared to controls (0.0% for all parameters, except 27.6% for hyposmia). Complete loss of bitter taste was the most prevalent specific ageusia (66.7%) and coffee was the most common distorted smell (56.4%). Seven different combinations of dysfunction were observed in the patients, the most common being a combination of olfactory and gustatory dysfunction (48.0%). These findings indicate that post-COVID-19 patients experience a range of chemosensory, trigeminal, and salivary disturbances, occurring in various combinations.

Citing Articles

Unveiling the Oral Lesions, Dysgeusia and Osteonecrosis Related to COVID-19: A Comprehensive Systematic Review.

Aliberti A, Gasparro R, Mignogna M, Canfora F, Spagnuolo G, Sammartino G J Clin Med. 2025; 14(4).

PMID: 40004799 PMC: 11856591. DOI: 10.3390/jcm14041267.

Parosmia: Pathophysiology and Management.

Xu X, Juratli J, Landis B, Hummel T Curr Allergy Asthma Rep. 2025; 25(1):10.

PMID: 39821581 DOI: 10.1007/s11882-024-01189-z.

Reduced Salivary Gustin and Statherin in Long-COVID Cohort with Impaired Bitter Taste.

Chowdary H, Riley N, Patel P, Gossweiler A, Running C, Srinivasan M J Clin Med. 2024; 13(22).

PMID: 39597960 PMC: 11594764. DOI: 10.3390/jcm13226816.

IL-8 (CXCL8) Correlations with Psychoneuroimmunological Processes and Neuropsychiatric Conditions.

Shkundin A, Halaris A J Pers Med. 2024; 14(5).

PMID: 38793070 PMC: 11122344. DOI: 10.3390/jpm14050488.

References

Butowt R, Bilinska K, von Bartheld C . Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms. Trends Neurosci. 2022; 46(1):75-90. PMC: 9666374. DOI: 10.1016/j.tins.2022.11.003. View

Niklassen A, Ovesen T, Fernandes H, Fjaeldstad A . Danish validation of sniffin' sticks olfactory test for threshold, discrimination, and identification. Laryngoscope. 2017; 128(8):1759-1766. DOI: 10.1002/lary.27052. View

Lechien J, Chiesa-Estomba C, De Siati D, Horoi M, Le Bon S, Rodriguez A . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8):2251-2261. PMC: 7134551. DOI: 10.1007/s00405-020-05965-1. View

Iwasaki M, Yoshihara A, Ito K, Sato M, Minagawa K, Muramatsu K . Hyposalivation and dietary nutrient intake among community-based older Japanese. Geriatr Gerontol Int. 2015; 16(4):500-7. DOI: 10.1111/ggi.12500. View

Witt M . Anatomy and development of the human taste system. Handb Clin Neurol. 2019; 164:147-171. DOI: 10.1016/B978-0-444-63855-7.00010-1. View

Parker J, Methven L, Pellegrino R, Smith B, Gane S, Kelly C . Emerging Pattern of Post-COVID-19 Parosmia and Its Effect on Food Perception. Foods. 2022; 11(7). PMC: 8997629. DOI: 10.3390/foods11070967. View

Ohla K, Veldhuizen M, Green T, Hannum M, Bakke A, Moein S . A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss. Rhinology. 2022; 60(3):207-217. PMC: 11016179. DOI: 10.4193/Rhin21.415. View

Breslin P . An evolutionary perspective on food and human taste. Curr Biol. 2013; 23(9):R409-18. PMC: 3680351. DOI: 10.1016/j.cub.2013.04.010. View

de Oliveira J, de Avila R, de Oliveira N, da Cunha Severino Sampaio N, Botelho M, Goncalves F . Persistent symptoms, quality of life, and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil. Int J Infect Dis. 2022; 122:1044-1051. PMC: 9330427. DOI: 10.1016/j.ijid.2022.07.063. View

10.

Cosentino G, Maiorano E, Todisco M, Prunetti P, Antoniazzi E, Tammam G . Electrophysiological evidence of subclinical trigeminal dysfunction in patients with COVID-19 and smell impairment: A pilot study. Front Neurol. 2022; 13:981888. PMC: 9615421. DOI: 10.3389/fneur.2022.981888. View

11.

Greenhalgh T, Knight M, ACourt C, Buxton M, Husain L . Management of post-acute covid-19 in primary care. BMJ. 2020; 370:m3026. DOI: 10.1136/bmj.m3026. View

12.

Norgren R . The gustatory system in mammals. Am J Otolaryngol. 1983; 4(4):234-7. DOI: 10.1016/s0196-0709(83)80064-7. View

13.

Zhong M, Lin B, Pathak J, Gao H, Young A, Wang X . ACE2 and Furin Expressions in Oral Epithelial Cells Possibly Facilitate COVID-19 Infection via Respiratory and Fecal-Oral Routes. Front Med (Lausanne). 2020; 7:580796. PMC: 7758442. DOI: 10.3389/fmed.2020.580796. View

14.

Kataoka S, Yang R, Ishimaru Y, Matsunami H, Sevigny J, Kinnamon J . The candidate sour taste receptor, PKD2L1, is expressed by type III taste cells in the mouse. Chem Senses. 2007; 33(3):243-54. PMC: 2642677. DOI: 10.1093/chemse/bjm083. View

15.

Landis B, Welge-Luessen A, Bramerson A, Bende M, Mueller C, Nordin S . "Taste Strips" - a rapid, lateralized, gustatory bedside identification test based on impregnated filter papers. J Neurol. 2009; 256(2):242-8. DOI: 10.1007/s00415-009-0088-y. View

16.

Blomberg B, Mohn K, Brokstad K, Zhou F, Linchausen D, Hansen B . Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021; 27(9):1607-1613. PMC: 8440190. DOI: 10.1038/s41591-021-01433-3. View

17.

Doyle M, Appleton A, Liu Q, Yao Q, Mazucanti C, Egan J . Human Type II Taste Cells Express Angiotensin-Converting Enzyme 2 and Are Infected by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Am J Pathol. 2021; 191(9):1511-1519. PMC: 8179718. DOI: 10.1016/j.ajpath.2021.05.010. View

18.

Manganotti P, Bellavita G, DAcunto L, Tommasini V, Fabris M, Sartori A . Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barré syndrome and polyneuritis cranialis in COVID-19 patients: A case series. J Med Virol. 2020; 93(2):766-774. PMC: 7405169. DOI: 10.1002/jmv.26289. View

19.

Gupta A, Epstein J, Sroussi H . Hyposalivation in elderly patients. J Can Dent Assoc. 2006; 72(9):841-6. View

20.

Boscolo-Rizzo P, Hopkins C, Menini A, Dibattista M, Cancellieri E, Gardenal N . Parosmia assessment with structured questions and its functional impact in patients with long-term COVID-19-related olfactory dysfunction. Int Forum Allergy Rhinol. 2022; 12(12):1570-1574. PMC: 9350240. DOI: 10.1002/alr.23054. View